Cargando…

Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia

The clinical course of patients with recently diagnosed early stage chronic lymphocytic leukemia (CLL) is highly variable. We examined the relationship between CLL-cell birth rate and treatment-free survival (TFS) in 97 patients with recently diagnosed, Rai stage 0–II CLL in a blinded, prospective s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murphy, Elizabeth J., Neuberg, Donna S., Rassenti, Laura Z., Hayes, Greg, Redd, Robert, Emson, Claire, Li, Kelvin, Brown, Jennifer R., Wierda, William G., Turner, Scott, Greaves, Andrew W., Zent, Clive S., Byrd, John C., McConnel, Coline, Barrientos, Jacqueline, Kay, Neil, Hellerstein, Marc K., Chiorazzi, Nicholas, Kipps, Thomas J., Rai, Kanti R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462857/ https://www.ncbi.nlm.nih.gov/pubmed/28115735 http://dx.doi.org/10.1038/leu.2017.34

Ejemplares similares

Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia
por: Kaufman, Matthew, et al.
Publicado: (2022)

Lack of Allelic Exclusion in B Cell Chronic Lymphocytic Leukemia
por: Rassenti, Laura Z., et al.
Publicado: (1997)

Correction to: Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells
por: Calissano, Carlo, et al.
Publicado: (2022)

Characterization of the Intraclonal Complexity of Chronic Lymphocytic Leukemia B Cells: Potential Influences of B-Cell Receptor Crosstalk with Other Stimuli
por: Mazzarello, Andrea N., et al.
Publicado: (2023)

Wnt5a causes ROR1 to complex and activate cortactin to enhance migration of chronic lymphocytic leukemia cells
por: Hasan, Md Kamrul, et al.
Publicado: (2018)

Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia
por: Rosenwald, Andreas, et al.
Publicado: (2001)

RITUXIMAB IN COMBINATION WITH HIGH DOSE METHYLPREDNISOLONE FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
por: Castro, Januario E., et al.
Publicado: (2009)

Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes
por: Sherry, Barbara, et al.
Publicado: (2015)

A Detailed Analysis of Parameters Supporting the Engraftment and Growth of Chronic Lymphocytic Leukemia Cells in Immune-Deficient Mice
por: Patten, Piers E. M., et al.
Publicado: (2021)

Subclonal evolution involving SF3B1 mutations in chronic lymphocytic leukemia
por: Schwaederlé, M, et al.
Publicado: (2013)

Contrasting Fecal Methanogenic and Bacterial Profiles of Organic Dairy Cows Located in Northwest Washington Receiving Either a Mixed Diet of Pasture and TMR or Solely TMR
por: Slanzon, Giovana, et al.
Publicado: (2022)

The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience
por: Van Dyke, Daniel L., et al.
Publicado: (2016)

Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia
por: Kämpjärvi, Kati, et al.
Publicado: (2014)

Chylothorax in Patients With Chronic Lymphocytic Leukemia: A Case Series
por: Sammartino, Daniel, et al.
Publicado: (2018)

Wnt5a enhances proliferation of chronic lymphocytic leukemia and ERK1/2 phosphorylation via a ROR1/DOCK2-dependent mechanism
por: Hasan, Md Kamrul, et al.
Publicado: (2020)

Differentiation of Chronic Lymphocytic Leukemia B Cells into Immunoglobulin Secreting Cells Decreases LEF-1 Expression
por: Gutierrez, Albert, et al.
Publicado: (2011)

High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia
por: Ghia, Emanuela M., et al.
Publicado: (2022)

Overview of recent developments in chronic lymphocytic leukemia
por: Jain, Preetesh, et al.
Publicado: (2012)

FcγRIIb-BCR coligation inhibits B-cell receptor signaling in chronic lymphocytic leukemia
por: Bosch, Rosa, et al.
Publicado: (2020)

B-cell Receptor Signaling Induced Metabolic Alterations in Chronic Lymphocytic Leukemia Can Be Partially Bypassed by TP53 Abnormalities
por: Kluckova, Katarina, et al.
Publicado: (2022)

Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells
por: Hasan, M K, et al.
Publicado: (2017)

Charges associated with pediatric head injuries: a five year retrospective review of 41 pediatric hospitals in the US
por: Robertson, Brian D., et al.
Publicado: (2013)

Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target
por: Palacios, Florencia, et al.
Publicado: (2021)

Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib
por: Yu, J, et al.
Publicado: (2017)

Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia
por: Walker, Janek S., et al.
Publicado: (2021)

AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression
por: Oppezzo, Pablo, et al.
Publicado: (2021)

Epstein–Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival()
por: Ferrajoli, Alessandra, et al.
Publicado: (2015)

Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia
por: Messmer, Bradley T., et al.
Publicado: (2004)

Therapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemia
por: Rai, Kanti R.
Publicado: (2015)

Chronic Lymphocytic Leukemia B Cells Can Undergo Somatic Hypermutation and Intraclonal Immunoglobulin V(H)DJ(H) Gene Diversification
por: Gurrieri, Carmela, et al.
Publicado: (2002)

The TKI Era in Chronic Leukemias
por: De Novellis, Danilo, et al.
Publicado: (2021)

Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical Course
por: Bagnara, Davide, et al.
Publicado: (2021)

Variable Cognition in ABM Decision-Making: An Application to Livestock Vaccine Choice
por: Iles, Richard A., et al.
Publicado: (2020)

Parenteral Antimicrobial Treatment Diminishes Fecal Bifidobacterium Quantity but Has No Impact on Health in Neonatal Dairy Calves: Data From a Field Trial
por: O'Keefe, Olivia C., et al.
Publicado: (2021)

Acalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemia
por: Wallace, Danielle S., et al.
Publicado: (2023)

Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells
por: Yu, J, et al.
Publicado: (2017)

BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia
por: Chen, S-S, et al.
Publicado: (2016)

Recent Advances in CAR T-Cell Therapy for Patients with Chronic Lymphocytic Leukemia
por: Heyman, Benjamin M., et al.
Publicado: (2022)

B cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemia
por: Mazzarello, Andrea N., et al.
Publicado: (2022)

Sleep Medication Use by people with Cerebral Palsy: A Population Level Data Linkage Study.
por: Kent, Lisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iqhhu8a3laaqru867jeohnf44e